FDA Adverse Event Malfunction Summary report: N

ARCHITECT CREATINE KINASE

MDR report key: 7709262 · Received July 21, 2018

Report

Report Number
1628664-2018-00330
Event Type
Malfunction
Date Received
July 21, 2018
Report Date
July 21, 2018
Manufacturer
ABBOTT MANUFACTURING INC
Product Code
CGS
UDI-DI
00380740012878
PMA / PMN Number
K983070
Removal / Correction Number
1628664-07/19/18-002-R
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

THE INITIAL MANUFACTURER REPORT WAS INADVERTENTLY MISSING THE 510K NUMBER, WHICH WAS ADDED TO SECTION PMA/510K (K983070). THERE ARE NO FURTHER UPDATES OR CHANGES.

Additional Manufacturer Narrative · 1

A PRODUCT RECALL LETTER WAS ISSUED TO ALL ARCHITECT CUSTOMERS WHO HAVE RECEIVED ARCHITECT CREATINE KINASE, LIST NUMBER 07D63-21, LOT NUMBER 87697UN18. THE LETTER INFORMS THE CUSTOMER OF THE ISSUE REGARDING A STABILITY ISSUE THAT MAY LEAD TO QUALITY CONTROL RESULTS SHIFTING LOW OUT OF RANGE AND/OR ERROR CODE 1054 "UNABLE TO CALCULATE RESULT, REACTION CHECK FAILURE" FOR QUALITY CONTROL AND PATIENT SAMPLES. THE LETTER INSTRUCTS THE CUSTOMER TO DISCONTINUE USE OF THE SUSPECT LOTS AND DESTROY ANY REMAINING INVENTORY. THE CAUSE OF THE STABILITY FAILURE HAS BEEN TRACED TO A CONTAMINATION OF THE BULK MATERIAL.

Description of Event or Problem · 1

THE CUSTOMER OBSERVED TRICHOPATHY QUALITY CONTROL SHIFT DOWN ON ALL 3 LEVELS WHEN USING THE CK ASSAY (LIST NUMBER 7D63, LOT NUMBER 87697UN18). NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
550689 ARCHITECT CREATINE KINASE CREATINE KINASE (CK) CGS ABBOTT MANUFACTURING INC 87697UN18 00380740012878

Patients

Seq Age Sex Outcome Treatment
1 ARCHITECT C8000| ARCHITECT C8000| LN 01G06 SN (B)(6)| LN 01G06 SN (B)(6)